Behcet's disease:: An update on the pathogenesis

被引:0
|
作者
Gül, A [1 ]
机构
[1] Univ Istanbul, Fac Med, Div Rheumatol, Dept Internal Med, TR-34390 Istanbul, Turkey
关键词
Behcet's disease; HLA-B51; complex genetic disease; tumor necrosis factor; pathergy; cytokines; heat shock proteins; gamma delta T-cell; vasculitis; endothelial activation; thrombotic tendency;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Behcet's disease is a chronic inflammatory disorder of unknown etiology. It has long been postulated that immunological abnormalities, which are possibly induced by, microbial pathogens in genetically susceptible individuals, are important in its pathogenesis. Recent findings have both supported the significance of genetic factors and better defined the nature of inflammation in Behcet's disease. Molecular genetic studies have strengthened the primary association of HLA-B51 with Behcet's disease. The exact pathogenic mechanism of the HLA-B51 molecule is still unknown, and its contribution to the overall genetic susceptibility to Behcet's disease is estimated to be less than 20%. Spontaneous and/or induced overexpression of pro-inflammatory cytokines (mainly Th1 type)from various cellular sources seems responsible for the enhanced inflammatory reaction in Behcet's disease, and it may be associated with the genetic susceptibility . An antigen-driven immune response superimposed on this primed-state and induced by heat shock proteins or other peptides,from different strains of streptoccocci or other microbial agents has been suggested to trigger manifestations of Behcet's disease. Endothelial activation/injury and the resultant occlusive vasculopathy may also contribute to the tissue damage.
引用
收藏
页码:S6 / S12
页数:7
相关论文
共 50 条
  • [41] Parkinson’s disease: an update on pathogenesis and treatment
    Tom Foltynie
    Joshua Kahan
    Journal of Neurology, 2013, 260 : 1433 - 1440
  • [42] An update on the diagnosis, treatment, and prognosis of intestinal Behcet's disease
    Cheon, Jae Hee
    Kim, Won Ho
    CURRENT OPINION IN RHEUMATOLOGY, 2015, 27 (01) : 24 - 31
  • [43] Is Behcet's disease a "class 1-opathy'? The role of HLA-B*51 in the pathogenesis of Behcet's disease
    Giza, M.
    Koftori, D.
    Chen, L.
    Bowness, P.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2018, 191 (01): : 11 - 18
  • [44] Dual effects of testosterone in Behcet's disease: implications for a role in disease pathogenesis
    Yavuz, S.
    Akdeniz, T.
    Hancer, V.
    Bicakcigil, M.
    Can, M.
    Yanikkaya-Demirel, G.
    GENES AND IMMUNITY, 2016, 17 (06) : 335 - 341
  • [45] Dual effects of testosterone in Behcet's disease: implications for a role in disease pathogenesis
    S Yavuz
    T Akdeniz
    V Hancer
    M Bicakcigil
    M Can
    G Yanikkaya-Demirel
    Genes & Immunity, 2016, 17 : 335 - 341
  • [46] An update on Behcet's syndrome
    Xenitidis, Theodoros
    Henes, Joerg Christoph
    LARYNGO-RHINO-OTOLOGIE, 2024, 103 (05) : 352 - 357
  • [47] DUAL EFFECTS OF TESTOSTERONE IN BEHCET'S DISEASE: IMPLICATIONS FOR A ROLE IN DISEASE PATHOGENESIS
    Akdeniz, T.
    Demirel, G. Y.
    Karakas, M.
    Bicakcigil, M.
    Direskeneli, H.
    Deyneli, O.
    Yavuz, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 232 - 233
  • [48] Update on Behcet's syndrome
    Dinc, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 16 - 16
  • [49] Ocular Manifestations of Behcet's Disease: An Update on Diagnostic Challenges and Disease Management
    Zajac, Hanna
    Turno-Krecicka, Anna
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (21)
  • [50] IMMUNOGENETICAL ANALYSIS FOR THE PATHOGENESIS OF BEHCET DISEASE
    NISHIMURA, Y
    NISHIMURA, Y
    SASAZUKI, T
    MINESHITA, S
    JAPANESE JOURNAL OF HUMAN GENETICS, 1981, 26 (02): : 166 - 166